XNYS · Healthcare · Medical Instruments & Supplies
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 1.90 | 2.55 | +34.21% | $2.21B | ✅ Beat | +2.89% | -2.49% | — |
| 2026-05-05 | Q1 2026 | 1.35 | 1.48 | +9.63% | $2.01B | ✅ Beat | -2.79% | +8.78% | +19.38% |
| 2026-02-26 |
| Q4 2025 |
| 1.50 |
| 1.57 |
| +4.67% |
| $2.00B |
| ✅ Beat |
| -2.52% |
| -8.01% |
| -18.43% |
| 2025-11-06 | Q3 2025 | 1.43 | 1.50 | +4.90% | $2.10B | ✅ Beat | — | — | — |
| 2025-08-07 | Q2 2025 | 1.45 | 1.69 | +16.55% | $2.16B | ✅ Beat | +4.99% | +1.74% | +1.07% |
| 2025-02-27 | Q4 2024 | 1.32 | 1.41 | +6.82% | $2.07B | ✅ Beat | -4.42% | -9.23% | -8.87% |
| 2024-11-07 | Q3 2024 | 1.39 | 1.64 | +17.99% | $2.08B | ✅ Beat | -3.52% | -9.55% | -5.91% |
Showing last 7 quarters.